Table 1. Baseline characteristics of the patients in the cohort.
| AF (n=23) | Control (n=37) | P-value | |
|---|---|---|---|
| Age (y) | 62.15 ± 14.18 | 61.62 ± 7.99 | ns |
| Female | 8 | 11 | ns |
| Hear rate (bpm) | 80.76 ± 15.06 | 72.21 ± 10.76 | <0.05 |
| sBP (mmHg) | 120.00 ± 14.32 | 133.15 ± 19.79 | ns |
| dBP (mmHg) | 75.65 ± 10.25 | 75.47 ± 11.49 | ns |
| EF (%) | 60.25 ± 11.87 | 63.74 ± 9.33 | ns |
| AST (U/l) | 23.24 ± 5.52 | 30.40 ± 47.19 | ns |
| ALT (U/l) | 25.69 ± 13.00 | 25.54 ± 15.60 | ns |
| CRE (mg/dl) | 8.01 ± 2.62 | 7.27 ± 1.22 | <0.05 |
| UA (mmol/l) | 342.58 ± 90.87 | 282.97 ± 84.11 | ns |
| TC (mg/dl) | 142.33 ± 35.27 | 153.66 ± 37.57 | ns |
| TG (mg/dl) | 135.19 ± 105.14 | 161.47 ± 162.15 | ns |
| HDL-C (mg/dl) | 40.03 ± 9.77 | 42.45 ± 14.69 | ns |
| LDL-C (mmol/l) | 1.99 ± 0.80 | 2.22 ± 0.75 | ns |
| proBNP (ng/ml) | 2616.93 ± 7274.73 | 251.58 ± 553.39 | <0.05 |
| FT4 (mmol/l) | 16.73 ± 3.43 | 16.26 ± 2.68 | ns |
| FT3 (mmol/l) | 5.12 ± 1.04 | 5.03 ± 0.88 | ns |
| TSH (mmol/l) | 2.50 ± 2.28 | 1.92 ± 1.17 | ns |
| Current/ex smoker (%) | 23.53% | 44.12% | |
| Current/ex drinker (%) | 11.76% | 29.41% | |
| DM (%) | 17.39% | 29.73% | |
| Hypertension (%) | 47.06% | 67.65% | |
| CHF (%) | 5.88% | 0.00% | |
| MI (%) | 11.76% | 11.76% |
Abbreviations: BP, blood pressure; CHF, chronic heart failure; TC, total cholesterol; DM, diabetes mellitus; EF, ejection fraction; FT3, free triiodothyronine; FT4, free thyroxine; MI, myocardial infarction; TSH, thyroid stimulating hormone.